ArticleBMJ open2026
Social prescribing for children and young people in the UK: characterising access and care pathways using electronic health records.
Article in BMJ open, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectivesWe aimed to describe the characteristics of children and young people referred to social prescribing across the UK and understand what social prescribing looks like for these young people. Additionally, we aimed to explore whether access to and experiences of social prescribing vary with age and have changed from 2017 to 2025. Overall, we aimed to identify whether social prescribing reduces or exacerbates health inequalities among children and young people, and whether this has changed over time.
designAnalysis of social prescribing electronic health records.
settingSocial prescribing hubs and services across the UK that use Access Elemental (a cloud-based social prescribing platform).
participants52 585 individuals referred to social prescribing in 2017-2025 aged 4-25 years (mean=20.04 years, SD=4.71), of whom 57% were female, 39% male, <2% were in other gender groups and 3% did not disclose their gender. PRIMARY AND SECONDARY OUTCOME MEASURES: We summarised young people's characteristics (age, gender, country, urban area, area deprivation, referral route, reason for referral) and the care pathway received (case status, number type and length of contacts, onward signposting and interventions) using descriptive statistics. We then used unadjusted linear, logistic, multinomial logistic and negative binomial regression models to describe whether these factors differed by age and over time.
resultsMost individuals were aged 18 and over, 91% lived in urban areas and 58% lived in the top three most deprived deciles of the UK. Most were referred by general practitioners or other allied health workers (79%) and mental health was the leading reason for referral (44%). The typical pathway included 4.64 social prescribing contacts (SD=7.70) totalling 66 min (SD=108), with 34% receiving an onward referral to community support. The average age of those referred to social prescribing increased over time.
conclusionsOur findings indicate that relatively few children under 18 were referred to social prescribing and this disparity may be increasing. It was promising that children and young people referred to social prescribing were more likely to live in deprived areas. However, given current findings, more work is needed to increase the reach of social prescribing for children and young people across the UK.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.